Zevra Therapeutics, Inc. (ZVRA)

NASDAQ: ZVRA · Real-Time Price · USD

8.98

+0.19 (2.16%)

At close: Mar 6, 2026, 4:00 PM EST

9.05

+0.07 (0.76%)

After-hours: Mar 6, 2026, 7:59 PM EST

Zevra Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	54.44	33.79	43.05	65.47	112.35	4.21
Short-Term Investments	145.07	35.71	24.69	17.38	-	-
Cash & Short-Term Investments	199.51	69.5	67.74	82.85	112.35	4.21
Cash Growth	123.22%	2.60%	-18.24%	-26.26%	2566.65%	30.96%
Accounts Receivable	16.84	10.51	17.38	8.3	1.53	2.58
Inventory	1.37	1.97	-	-	-	-
Other Current Assets	7.4	4.05	1.82	1.69	1.18	1.59
Total Current Assets	225.12	86.03	86.94	92.83	115.06	8.38
Net Property, Plant & Equipment	1.83	1.01	1.53	1.78	2.03	2.39
Other Intangible Assets	6.74	68.99	69.23	-	-	-
Goodwill	4.7	4.7	4.7	-	-	-
Long-Term Investments	30.87	6.01	-	20	15.42	-
Other Long-Term Assets	0.87	11.38	9.94	0.72	0.44	0.44
Total Assets	270.12	178.13	172.33	115.34	132.94	11.21
Accounts Payable	11.07	25.46	28.4	6.17	3.04	6.65
Short-Term Debt	-	-	37.7	-	-	-
Current Portion of Long-Term Debt	-	-	-	-	-	0.39
Current Portion of Leases	0.44	0.42	0.54	0.48	0.36	0.33
Other Current Liabilities	14.6	8.19	7.07	5.37	0.84	0.17
Total Current Liabilities	26.11	34.07	73.72	12.02	4.23	7.54
Long-Term Debt	61.31	59.5	5.07	12.8	-	68.05
Long-Term Leases	0.97	0.37	0.46	0.84	1.23	1.59
Other Long-Term Liabilities	48.56	44.52	31.22	14.55	0.36	0.45
Total Long-Term Liabilities	110.84	104.4	36.74	28.2	1.59	70.09
Total Liabilities	136.95	138.46	110.46	40.22	5.82	77.62
Common Stock	0.01	0.01	0	0	0	0
Treasury Stock	-10.98	-10.98	-10.98	-7.54	-2.81	-
Additional Paid-in Capital	580.78	555.3	472.66	436.27	396.96	192.06
Accumulated Other Comprehensive Income	-2.42	0.63	-0.04	0.11	-	-
Retained Earnings	-434.23	-505.29	-399.78	-353.73	-267.03	-258.47
Shareholders' Equity	133.17	39.67	61.86	75.12	127.12	-66.41
Total Liabilities & Equity	270.12	178.13	172.33	115.34	132.94	11.21
Total Debt	62.72	60.3	43.77	14.12	1.59	70.35
Net Cash (Debt)	136.79	9.2	23.97	68.72	110.76	-66.14
Net Cash Growth	1386.87%	-61.62%	-65.12%	-37.95%	-	-
Net Cash Per Share	2.49	0.20	0.68	1.99	3.72	-16.61
Book Value	133.17	39.67	61.86	75.12	127.12	-66.41
Book Value Per Share	2.42	0.86	1.74	2.18	4.27	-16.68
Tangible Book Value	121.73	-34.03	-12.06	75.12	127.12	-66.41
Tangible Book Value Per Share	2.21	-0.74	-0.34	2.18	4.27	-16.68

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q